SCHEMBL4473520

SCHEMBL4473520

CCCN1CCCC(C)(C)C1

nearest known ligand 0.70

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12674147 0.86 S1PR4 (0.36) MAOB
SCHEMBL81260 0.82 TSHR (0.41) MAOB
SCHEMBL7780265 0.81 ALOX15 (0.42) MAOB
SCHEMBL6049584 0.81 MAOB (0.40) MAOB
SCHEMBL30598302 0.79 S1PR4 (0.36) MAOB
SCHEMBL30598274 0.79 S1PR4 (0.36) MAOB
SCHEMBL29646170 0.79 S1PR4 (0.36) MAOB
SCHEMBL13564382 0.79 ADORA2A (0.34) MAOB
SCHEMBL6890187 0.77 OPRM1 (0.35)
SCHEMBL16980435 0.76 MAOB (0.30) MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916699-A Low pressure synthesis of zeolite SSZ-13 雪佛龙美国公司 2023-04-04 CN claimed
CN-112969662-A Aluminosilicate zeolite intergrowth 巴斯夫公司 2021-06-15 CN claimed
CN-111655620-A Method for preparing a zeolitic material comprising Ti and having a CHA framework-type 巴斯夫欧洲公司 2020-09-11 CN claimed
CN-110831898-A Composition comprising a zeolitic material supported on a support material 巴斯夫欧洲公司 2020-02-21 CN claimed
CN-115916699-B Low-pressure synthesis of zeolite SSZ-13 雪佛龙美国公司 2024-05-07 CN disclosed
CN-107427821-B Bimetallic molecular sieve catalysts 庄信万丰股份有限公司 2023-11-10 CN disclosed
US-20230339902-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2023-10-26 US disclosed
US-20230339902-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2023-10-26 US disclosed
CN-116829506-A JMZ-12, disordered AEI/CHA family of zeolites, their synthesis and use 庄信万丰股份有限公司 2023-09-29 CN disclosed
CN-115916699-A Low pressure synthesis of zeolite SSZ-13 雪佛龙美国公司 2023-04-04 CN disclosed
CN-108778997-B Method for the rapid calcination of zeolitic materials 巴斯夫欧洲公司 2023-01-17 CN disclosed
CN-109311006-B Copper-promoted gmelinite and its use in selective catalytic reduction of NOx 巴斯夫公司 2022-09-27 CN disclosed
CN-105742077-A POWER STORAGE DEVICE, LITHIUM-ION SECONDARY BATTERY, ELECTRIC DOUBLE LAYER CAPACITOR AND LITHIUM-ION CAPACITOR 株式会社半导体能源研究所 2016-07-06 CN disclosed
CN-102332609-B Power storage device, lithium ion secondary battery, electric double layer capacitor, and lithium ion capacitor 株式会社半导体能源研究所 2016-06-22 CN disclosed
CN-104518238-A Power storage device SEMICONDUCTOR ENERGY LAB 2015-04-15 CN disclosed
CN-104241689-A Nonaqueous solvent, nonaqueous electrolyte, and power storage device SEMICONDUCTOR ENERGY LAB 2014-12-24 CN disclosed
US-7897778-B2 Benzamide compounds ASTRAZENECA (SE) 2011-03-01 US disclosed
EP-2038059-A1 TREATMENT OF CHA-TYPE MOLECULAR SIEVES AND THEIR USE IN THE CONVERSION OF OXYGENATES TO OLEFINS Exxonmobil Chemical Patents Inc. A Corporation Of The State Of Delaware (US) 2009-03-25 EP disclosed
US-20080293687-A1 Benzamide Compounds ASTRAZENECA AB (SE) 2008-11-27 US disclosed
WO-2007145724-A1 TREATMENT OF CHA-TYPE MOLECULAR SIEVES AND THEIR USE IN THE CONVERSION OF OXYGENATES TO OLEFINS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339902-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 IKZF1, IKZF3, IKZF2 MAOB 4489/4885
US-20080293687-A1 Benzamide Compounds HDAC1, HDAC11, HDAC2 MAOB 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.